$35.84
+1.30 (+3.76%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-7.82%
1Y
+393.66%
YTD
+3.17%
Open$35.34
Previous Close$34.54
Day High$36.03
Day Low$35.02
52W High$43.73
52W Low$6.92
Volume—
Avg Volume2.31M
Market Cap5.90B
P/E Ratio—
EPS$-2.51
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$37.85
Below
SMA 200
$20.09
Above
RSI (14)
53
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+134.3% upside
Current
$35.84
$35.84
Target
$83.97
$83.97
$51.90
$83.97 avg
$108.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.66B | 1.76B | 1.56B |
| Net Income | -282,006,496 | -354,880,166 | -268,142,716 |
| Profit Margin | -17.0% | -20.2% | -17.2% |
| EBITDA | -474,772,680 | -496,954,417 | -453,512,070 |
| Free Cash Flow | -249,995,996 | -301,722,393 | -268,935,506 |
| Rev Growth | -0.8% | +1.9% | -1.2% |
| Debt/Equity | 0.59 | 0.54 | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |